Skip to main content

Day: December 4, 2023

DayDayCook Announces Share Repurchase Program

Program authorizes up to 500,000 Class A Ordinary Shares to be repurchased NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) — DDC Enterprise Ltd, (NYSEAM: DDC) (“DayDayCook” or the “Company”), a leading content-driven food consumer brand, today announces that its Board of Directors approved a 10b-18 share repurchase program with authorization to purchase up to 500,000 of the Company’s Class A Ordinary Shares. This plan is effective immediately for up to a one-year period. “Following our initial public offering, we remain dedicated to prudent allocation of capital focused on long-term growth opportunities. We believe this share repurchase reflects the Board’s and Management’s confidence in our business, as well as the value we place on shareholder equity,” said DayDayCook CEO Norma Chu. The Company may repurchase Class A Ordinary Shares...

Continue reading

AB Linas Agro Group: notification on acquisition of block of shares of the Company

AB Linas Agro Group, ISIN code LT0000128092 (hereinafter – the Company), received a notification from UAB “SB Asset Management” on the acquisition of block of shares and voting rights of the Company (enclosed).Additional information: Mažvydas Šileika, Finance Director of AB Linas Agro Group Mob. +370 619 19 403 E-mail m.sileika@linasagro.ltAttachmentNotification-of-aquisition-of-block-of-shares LNA-s1204

Continue reading

Mullen Automotive Hires Basile Law Firm P.C. to Review Prior Financings and Provide Strategic Review of Future Funding Initiatives

Law firm engaged to assist the Company in reviewing its current fundings and to make recommendations in developing its floorplan for 2024 fundings BREA, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces today that it has hired Mark R. Basile, Esq. and his law firm, The Basile Law Firm P.C., to assist the Company in reviewing its current fundings and to make recommendations in developing its floorplan for future fundings. “Mullen is committed to full transparency to the public markets. We are making this announcement in an effort to notify our shareholders that we fully intend to take any and all measures necessary to continue our sustainable growth as we move ahead with previously announced strategic...

Continue reading

Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million

Los Angeles, CA, Dec. 04, 2023 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV), a commercial-stage developer of wearable products for pain relief, general wellness, and wound curatives marketed under the SofPulse® brand name, announced the signing of a definitive agreement for the sale of the SofPulse® business and medical Intellectual Property (IP) to SofPulse, Inc.. ENDV is expected to receive the greater of $50 million or a price to be determined by a qualified third party’s asset valuation acceptable to the Endonovo board. It was further agreed, that SofPulse, Inc. will prepare to fulfill the regulatory requirements for a NASDAQ listing following the sale’s completion. To fuel SofPulse, Inc. operations, the company aims to conduct a capital raise of up to $500,000 through a 506 offering tailored for...

Continue reading

TMT Acquisition Corp Announces Entering into a Merger Agreement with eLong Power, a Specialty Battery Technologies Provider for Applications in Commercial EV and Energy Storage

Transaction anticipated to close in the first half of 2024 NEW YORK, N.Y. and Ganzhou, China, Dec. 04, 2023 (GLOBE NEWSWIRE) — TMT Acquisition Corp (“TMTC”) (NASDAQ: TMTCU), a publicly traded special purpose acquisition company (SPAC), and eLong Power Holding Limited (“eLong Power”), a provider of high power battery technologies for commercial and specialty vehicles and energy storage systems, today announced that they have entered into a definitive business combination agreement, dated December 1, 2023, that will result in eLong Power becoming a publicly traded company. Huizhou Yipeng Energy Technology Co., Ltd. (“Yipeng Huizhou”, together with eLong Power, the “Company”) is the operating entity of eLong Power. Upon the closing of the transaction, the combined company is expected to be named eLong Power Inc. and its securities...

Continue reading

LKQ Corporation Announces New Leadership Appointments

John Meyne appointed Senior Vice President of LKQ and President of its Wholesale – North America segmentAndy Hamilton appointed Senior Vice President of LKQ and President of its European segmentCHICAGO, Dec. 04, 2023 (GLOBE NEWSWIRE) — LKQ Corporation (Nasdaq: LKQ) previously announced that Justin Jude, the Company’s current Senior Vice President and President of its Wholesale – North America segment, has been appointed to serve as LKQ’s Executive Vice President and Chief Operating Officer from January 1, 2024 until he officially succeeds Dominick Zarcone as President and Chief Executive Officer of LKQ on July 1, 2024. Today, the Company is announcing two additional leadership appointments. First, the Company’s Board of Directors (the “Board”) has appointed John Meyne, currently the East Division Vice President of LKQ’s Wholesale – North...

Continue reading

Pharmaceutical Excipients Market Size Worth USD 10.43 Billion in 2032 | Emergen Research

Rising demand for functional excipients and oral pharmaceutical medicines and increasing number of pharmaceuticals industries across the globe are key factors driving Pharmaceutical Excipients market revenue growth. Vancouver, Dec. 04, 2023 (GLOBE NEWSWIRE) — The global pharmaceutical excipients market size was USD 6.00 Billion in 2022 and is expected to register a rapid revenue CAGR of 5.7% during the forecast period. The global pharmaceutical excipients market is experiencing substantial growth, primarily fueled by the rising demand for functional excipients and oral pharmaceutical medicines worldwide. The market is also driven by the expansion of pharmaceutical industries and an increasing preference for generic medications. Pharmaceutical excipients, inert chemicals integral to drug manufacturing, play a pivotal role in enhancing...

Continue reading

Smart Glass Market Size Worth USD 26.65 Billion in 2032 | Emergen Research

The growth of Smart Glass Market is attributed to the growing demand for smart glass in automobile sector and declining prices of electrochemical materials Vancouver, Dec. 04, 2023 (GLOBE NEWSWIRE) — The global Smart Glass Market is projected to reach USD 26.65 billion by 2032, according to a recent report by Emergen Research. Renewed confidence of consumers within the economy coupled with greater spending boosted the sales of light-and heavy-duty vehicles. The demand for automotive glass is driven by several factors. The replacement volume of glasses is likely to grow with rise in the total vehicle population and kilometers driven. Severe weather and road conditions can also boost the demand for automotive glass repair and replacement. However, buyers tend to defer from fixing minor injury to a windscreen till a vehicle is held...

Continue reading

Smart Irrigation Market Size Worth USD 6,978.05 Billion in 2032 | Emergen Research

Increasing need to enhance landscape health and reduce water wastage and enhance efficiency of farming are some of the key factors driving Smart Irrigation market revenue growth Vancouver, Dec. 04, 2023 (GLOBE NEWSWIRE) — The global smart irrigation market size reached USD 1,476.3 Million in 2021 and is expected to register a revenue CAGR of 15.2% during the forecast period. Increasing need for smart notifications in case of abnormalities in irrigation process and remote access to real-time data are some key factors expected to drive market revenue growth. Water management is required to reduce water wastage so as to avoid water shortage in the future. Improper watering methods lead to water wastage through evaporation, wind, and runoff. Smart irrigation systems are designed to reduce the amount of water used in outdoor irrigation...

Continue reading

Brachytherapy Market Size Worth USD 670.92 Billion in 2032 | Emergen Research

Rising incidence of cancer is one of the most significant factors influencing the brachytherapy market growth. Vancouver, Dec. 04, 2023 (GLOBE NEWSWIRE) — The global brachytherapy market is projected to be worth USD 670.92 Million by 2032, according to a current analysis by Emergen Research. The brachytherapy market is experiencing an increased demand attributed to its growing application in the treatment of cancer. Cancer has a significant impact on global society. According to the statistics published by the National Cancer Institute, about 1,806,590 new cancer cases will be diagnosed in the US in 2020 and will account for the death of 606,520 individuals. In 2020, prostate, colorectal, and lung cancers will be responsible for a projected 43.0% diagnosed cases in men. On the other hand, breast, colorectal, and lung cancer are...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.